Lead company VOC Diagnostics took part in the winning team at the Sahlgrenska Global Health Hackathon – a global event engaging over 1,000 participants across six countries to find innovative solutions to some of the world’s greatest health challenges.
The winning concept, eNose Diagnostics, combines an electronic nose with machine learning to identify cancer through the chemical signatures released in blood – a groundbreaking approach with the potential to revolutionize early cancer detection.
VOC Diagnostics is an innovative medtech company focused on the early detection of ovarian cancer. Founded in 2017, the company is based on research from the University of Gothenburg led by Professor György Horváth, specialist in Obstetrics, Gynecology, and Gynecological Oncology. Its patented technology shows strong potential for diagnosing other cancers, including breast, lung, and prostate cancer.
The hackathon aimed to foster collaboration between innovators, researchers, clinicians, and entrepreneurs worldwide – encouraging bold thinking, cross-border partnerships, and technologies that can make a real impact on global health.
